Pulmatrix Inc PULM 深 滬
已收盤 02-06 16:00:00 美东时间
2.48
-0.010
-0.40%
華盛通- 最 高2.60
- 今 開2.50
- 成交量 8913股
- 最 低 2.48
- 昨 收 2.49
- 總市值 905.77万
- 52周最高 10.40
- 市盈率 靜 --
- 換手率 0.24%
- 52周最低 2.146
- 委 比 -5.60%
- 總股本 365.23万
- 歷史最高 4235.00
- 量 比 0.94
- 振 幅 4.82%
- 歷史最低 1.55
- 每 手 1
- 風險率 1.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulmatrix Mulls Divestment Of Clinical Assets, Proprietary iSPERSE Technology As Part Of Proposed Merger With Cullgen
As part of the proposed merger, Pulmatrix currently intends to divest its assets including its proprietary dry powder delivery technology, iSPERSE™, which enables delivery of small- or large-molecule drugs to the
2025-10-16 20:17
Pulmatrix Q3 EPS $(0.24) Up From $(0.71) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.24) per share. This is a 66.2 percent increase over losses of $(0.71) per share from the same period last year.
2025-10-16 20:14
Pulmatrix GAAP EPS of -$0.24
Pulmatrix press release (NASDAQ:PULM): Q3 GAAP EPS of -$0.24. The Company's total cash and cash equivalents balance as of September 30, 2025, was $4.8 million. The Company anticipates that its cash po...
2025-10-16 20:13
Pulmatrix Q2 EPS $(0.42) Up From $(1.59) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.42) per share. This is a 73.58 percent increase over losses of $(1.59) per share from the same period last year.
2025-08-06 20:16
Pulmatrix GAAP EPS of -$0.42
Pulmatrix press release (NASDAQ:PULM): Q2 GAAP EPS of -$0.42. The Company's total cash and cash equivalents balance as of June 30, 2025, was $5.8 million. The Company anticipates that its cash positio...
2025-08-06 20:16
Pulmatrix Seeks Divestment Of Clinical Assets And iSPERSE Inhalation Technology Amid Advancements In Migraine, COPD, And Antifungal Treatments
Pulmatrix Currently Seeking Divestment of Clinical Assets and Proprietary iSPERSE™ TechnologyiSPERSE™ TechnologyiSPERSE™ particles are engineered with a small, dense and dispersible profile to exceed
2025-08-06 20:15
Pulmatrix Stockholders Approve Merger with Cullgen
Pulmatrix ( ($PULM) ) has issued an update. On June 16, 2025, Pulmatrix held a ...
2025-06-17 04:53
Pulmatrix GAAP EPS of -$0.50
Pulmatrix press release (NASDAQ:PULM): Q1 GAAP EPS of -$0.50. The Company's total cash and cash equivalents balance as of March 31, 2025, was $7.7 million. The Company anticipates that its cash positi...
2025-05-15 20:24
Pulmatrix Q1 EPS $(0.50) Down From $0.23 YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.50) per share. This is a 317.39 percent decrease over earnings of $0.23 per share from the same period last year.
2025-05-15 20:21
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets
Announced merger agreement with Cullgen in November, anticipated to close in the first half of 2025 As part of proposed merger, Pulmatrix intends to divest its assets including its Phase 2-r...
2025-03-21 20:05
